Register Now - Every Drop Matters: Reducing Product Loss in Sterile Filtration
|Articles|September 1, 2015

BioPharm International

  • BioPharm International-09-01-2015
  • Volume 28
  • Issue 9

Biocontainer Assemblies Provide Repeatable Performance

Meissner’s FlexGro single-use biocontainer assemblies feature the TepoFlex polyethylene (PE) multi-layer film and are delivered presterilized for immediate use.

Meissner’s FlexGro single-use biocontainer assemblies, designed for use with rocker-style bioreactors, feature the TepoFlex polyethylene (PE) multi-layer film, are available in up to 50 L and are delivered presterilized for immediate use. The TepoFlex film offers a clean film platform, devoid of slip agents, which provides robust and repeatable performance for cell-cultivation processes, the company reports.  FlexGro biocontainer assemblies can be customized to specific end-user requirements via various sampling and process connection options, or companies can choose from standard assembly designs.

Meissner Filtration Productswww.meissner.com

 


Related to this article

The BioPharm Brief: Long-Term Survival Data for a PD-L1/4-1BB Bispecific, Celldex Exits Atopic Dermatitis, and a Fc-Fusion GLP-1 Goes Global
Leads Biolabs details survival data and 2027 ADC combination plans for its PD-L1/4-1BB bispecific opamtistomig, Celldex Therapeutics ends its atopic dermatitis program for anti-KIT antibody barzolvolimab after a phase 2 miss, and Innogen licenses its Fc-fusion GLP-1 receptor agonist efsubaglutide alfa to Arcera Life Sciences for international markets.
The BioPharm Brief: A Matrix-Targeting ADC in Head and Neck Cancer, an RNAi Approval in Myasthenia Gravis, and AbbVie Bets on AND-Gated Bispecifics
Pyxis Oncology’s EDB+FN-targeting ADC micvotabart pelidotin shows a 39% confirmed response rate in previously treated head and neck cancer, FDA approves Regeneron and Alnylam’s cemdisiran (Livsayis) as the first RNAi therapy for generalized myasthenia gravis, and AbbVie partners with DISCO Pharmaceuticals on AND-gated bispecifics for solid tumors.